Title | Engineered extrachromosomal oncogene amplifications promote tumorigenesis. |
Publication Type | Journal Article |
Year of Publication | 2025 |
Authors | Pradella D, Zhang M, Gao R, Yao MA, Gluchowska KM, Cendon-Florez Y, Mishra T, La Rocca G, Weigl M, Jiao Z, Nguyen HHM, Lisi M, Ozimek MM, Mastroleo C, Chen K, Grimm F, Luebeck J, Zhang S, Zolli AAlice, Sun EG, Dameracharla B, Zhao Z, Pritykin Y, Sigel C, Chang HY, Mischel PS, Bafna V, Antonescu CR, Ventura A |
Journal | Nature |
Volume | 637 |
Issue | 8047 |
Pagination | 955-964 |
Date Published | 2025 Jan |
ISSN | 1476-4687 |
Keywords | Animals, Carcinogenesis, Carcinoma, Hepatocellular, Cell Proliferation, Cell Transformation, Neoplastic, Disease Models, Animal, Female, Gene Amplification, Genetic Engineering, Humans, Liver Neoplasms, Male, Mice, Oncogenes, Proto-Oncogene Proteins c-mdm2 |
Abstract | Focal gene amplifications are among the most common cancer-associated mutations1 but have proven challenging to engineer in primary cells and model organisms. Here we describe a general strategy to engineer large (more than 1 Mbp) focal amplifications mediated by extrachromosomal DNAs (ecDNAs)2 in a spatiotemporally controlled manner in cells and in mice. By coupling ecDNA formation with expression of selectable markers, we track the dynamics of ecDNA-containing cells under physiological conditions and in the presence of specific selective pressures. We also apply this approach to generate mice harbouring Cre-inducible Myc- and Mdm2-containing ecDNAs analogous to those occurring in human cancers. We show that the engineered ecDNAs spontaneously accumulate in primary cells derived from these animals, promoting their proliferation, immortalization and transformation. Finally, we demonstrate the ability of Mdm2-containing ecDNAs to promote tumour formation in an autochthonous mouse model of hepatocellular carcinoma. These findings offer insights into the role of ecDNA-mediated gene amplifications in tumorigenesis. We anticipate that this approach will be valuable for investigating further unresolved aspects of ecDNA biology and for developing new preclinical immunocompetent mouse models of human cancers harbouring specific focal gene amplifications. |
DOI | 10.1038/s41586-024-08318-8 |
Alternate Journal | Nature |
PubMed ID | 39695225 |
PubMed Central ID | PMC11754114 |
Grant List | U24 CA264379 / CA / NCI NIH HHS / United States P30 CA008748 / CA / NCI NIH HHS / United States OT2 CA278635 / CA / NCI NIH HHS / United States OT2 CA278688 / CA / NCI NIH HHS / United States R01 CA282913 / CA / NCI NIH HHS / United States OT2 CA301085 / CA / NCI NIH HHS / United States CGCATF-2021/100012 / CRUK_ / Cancer Research UK / United Kingdom R01 GM114362 / GM / NIGMS NIH HHS / United States |
Submitted by est4003 on March 6, 2025 - 10:56am